Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 2 Datasets 392.5k Experiments 4.7k

Explore

Filters: Precision medicine ✕ 1 ✕ 1 ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature. PMID 37076665	NPJ Precis Oncol	2023	50	L1 50/100
Gene Set Enrichment Analysis Reveals Individual Variability in Host Responses in Tuberculosis Patients. PMID 34421903	Front Immunol	2021	71	71/100

Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature.

PMID 37076665 · NPJ Precis Oncol · 2023

L1 50/100

Gene Set Enrichment Analysis Reveals Individual Variability in Host Responses in Tuberculosis Patients.

PMID 34421903 · Front Immunol · 2021

71/100